Galderma Group AG (SWX: GALD)
77.63
-3.07 (-3.80%)
Sep 4, 2024, 9:35 AM CET
Galderma Group AG Company Description
Galderma Group AG operates as a dermatology company worldwide.
The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.
Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology.
The company was founded in 1981 and is headquartered in Zug, Switzerland.
Galderma Group AG
Country | Switzerland |
Founded | 1981 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 6,545 |
CEO | Flemming Ornskov |
Contact Details
Address: Zählerweg 10 Zug, 6300 Switzerland | |
Phone | 41 58 455 85 92 |
Website | galderma.com |
Stock Details
Ticker Symbol | GALD |
Exchange | SIX Swiss Exchange |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | CH1335392721 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Flemming Ornskov M.B.A., M.P.H. | Chief Executive Officer and Director |
Thomas J. W. Dittrich | Chief Financial Officer |
Adrian Murphy | Head of Global Operations |
Emil Ivanov | Head of Strategy, Investor Relations and ESG |
Christian Marcoux | Chief Communications Officer |
Allison Pinkham | Chief Human Resources Officer |